Please login to the form below

Not currently logged in
Email:
Password:

skin cancer

This page shows the latest skin cancer news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Merck/Pfizer’s PD-L1 inhibitor Bavencio for kidney cancer

NICE recommends Merck/Pfizer’s PD-L1 inhibitor Bavencio for kidney cancer

as a treatment for kidney cancer for use within the Cancer Drugs Fund. ... Bavencio is also approved for the rare skin cancer Merkel cell carcinoma and in second-line bladder cancer – although it is competing head-to-head in the latter indication with

Latest news

More from news
Approximately 19 fully matching, plus 126 partially matching documents found.

Latest Intelligence

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    For example, skin cancer patients who carry a BRAF V600 mutation are more likely to respond to BRAF inhibitors like Roche’s Zelboraf (Vemurafenib) than people without such mutations. ... He also cited an FDA-approved TMB test developed by Foundation

  • Digital health Digital health

    What digital health has delivered to date is amazing. The examples are legion: an application which can differentially diagnose lesions on skin with 20-30 times more accuracy than a doctor ... when it comes to skin cancer, or HealthTap’s Dr AI which

  • Case study: Skin cancer awareness

    Skin cancer is on the increase. It is one of the most common cancers in the 15-24 age group and a significant cause of death. ... Posters and leaflets do not get through to younger people; at this age they feel invincible and believe skin cancer will

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • CytomX appoints Rachel Humphrey chief medical officer CytomX appoints Rachel Humphrey chief medical officer

    Before her time at AZ and Eli Lilly, Humphrey was also VP of product development at Bristol-Myers Squibb where she led all aspects of clinical development of the skin-cancer

  • Kite Pharma appoints Zelboraf scientist as CMO Kite Pharma appoints Zelboraf scientist as CMO

    Keith Nolop joins US cancer biotech from Plexxikon. Dr Keith Nolop, one of the chief scientists behind the development of Roche's personalised skin cancer drug Zelboraf, has been appointed chief ... At Plexxikon, he also led the filing of eight

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Live Webinar: Using HealthTech to Deliver Better Patient Outcomes

    Fireside Chat with Peter Birch, General Manager (Asia Pacific) at MetaOptima Technology. In this international Fireside Chat, Natalie Yeadon will sit down with  Peter Birch, General Manager (Asia Pacific) at  MetaOptima Technologies &host of the

  • If our patients are diverse, why are clinical trials so white?

    How many times have you been told to put on sunscreen to prevent skin cancer? ... https://www.cdc.gov/cancer/skin/statistics/behavior/sunprotection. htm. https://www.ncbi.nlm.nih.gov/pubmed/15837865. https://www.sciencedirect.com/science/article/pii/

  • Battling breast cancer with precision medicine (Part 1)

    I was diagnosed with inflammatory breast cancer (IBC) with axillary lymph node involvement, including supraclavicular nodes. ... The cancer cells attack the skin and lymph vessels around the breast, and about 5, 000 cases are diagnosed every year in the

  • OPEN Health Graduates and the XP Support Group

    XP is a rare skin condition where individuals have an impaired ability to repair DNA damage caused by UV light, often resulting in dry skin, pigmentation and increased susceptibility to skin ... cancer. As a result, individuals have to avoid sunlight by

  • Is fear an effective driver of behaviour change?

    Liz, who knows she has a high risk for skin cancer due to family history and skin type, will be more likely to apply sun cream (provided it is easy for ... Leo, who knows he has a lower risk of skin cancer, or for whom the cost or convenience of applying

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics